Valuation Highnoon Laboratories Limited

Equities

End-of-day quote Pakistan S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
701.10 ^PKR	+0.16%		+0.34%	+38.95%

Aug. 29	Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
Jul. 22	Highnoon Laboratories Limited Announces Executive Changes	CI

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Capitalization ¹	9,945	16,907	20,762	23,906	22,624	26,733
Change	-	69.99%	22.81%	15.14%	-5.37%	18.17%
Enterprise Value (EV) ¹	9,326	16,200	19,350	21,404	21,785	25,855
Change	-	73.72%	19.44%	10.62%	1.78%	18.68%
P/E ratio	13.6x	16.9x	14.1x	12.9x	9.15x	10.9x
PBR	3.49x	4.9x	4.52x	4.04x	2.96x	2.66x
PEG	-	0.5x	0.3x	0.5x	0.3x	-10.77x
Capitalization / Revenue	1.33x	1.87x	1.94x	1.84x	1.43x	1.35x
EV / Revenue	1.24x	1.79x	1.81x	1.65x	1.38x	1.31x
EV / EBITDA	7.79x	11.3x	9.37x	8.63x	6.42x	7.23x
EV / EBIT	8.75x	12.3x	9.99x	9.25x	6.79x	7.65x
EV / FCF	32.1x	52.8x	23.5x	18.3x	-14.7x	40.8x
FCF Yield	3.12%	1.89%	4.25%	5.48%	-6.79%	2.45%
Dividend per Share ²	7.019	7.721	9.8	14.37	15.81	30
Rate of return	3.74%	2.42%	2.5%	3.19%	3.7%	5.95%
EPS ²	13.82	18.89	27.82	35.04	46.67	46.2
Distribution rate	50.8%	40.9%	35.2%	41%	33.9%	64.9%
Net sales ¹	7,503	9,048	10,698	13,001	15,816	19,766
EBITDA ¹	1,197	1,435	2,066	2,480	3,392	3,576
EBIT ¹	1,066	1,321	1,937	2,313	3,209	3,378
Net income ¹	732.2	1,001	1,474	1,856	2,473	2,448
Net Debt ¹	-619.8	-706.4	-1,412	-2,502	-838.5	-878.3
Reference price ²	187.71	319.09	391.87	451.20	427.00	504.56
Nbr of stocks (in thousands)	52,983	52,983	52,983	52,983	52,983	52,983
Announcement Date	4/5/19	4/21/20	4/1/21	3/28/22	4/14/23	4/9/24

¹PKR in Million²PKR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
ELI LILLY AND COMPANY	58.11x	18.01x	43.74x	+0.58%	812B
NOVO NORDISK A/S	38.54x	13.43x	27.34x	+1.30%	573B
JOHNSON & JOHNSON	21.43x	4.63x	13.14x	+2.80%	403B
ABBVIE INC.	38.8x	7.32x	15.82x	+3.13%	352B
MERCK & CO., INC.	15.38x	4.89x	11.2x	+2.67%	292B
ASTRAZENECA PLC	28.97x	5.21x	15.46x	+1.91%	251B
ROCHE HOLDING AG	16.05x	3.81x	9.97x	+3.66%	255B
NOVARTIS AG	21.08x	4.99x	12.63x	+3.24%	236B
AMGEN INC.	50.67x	6.84x	11.97x	+2.79%	177B
Average	32.11x	7.68x	17.92x	+2.45%	372.42B
Weighted average by Cap.	36.21x	9.80x	22.93x	+2.06%